Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 31-Jan-23 7:04 PM View:  | Pakianathan Deepika Director | Calithera Biosciences, Inc. (CALA) | 27-Jan-23 | Sale | 121,333 | $0.39 | $46,810.30 | (100%) 121.33K to 0 | |
| 25-Jan-23 4:00 PM View: | Kuriakose Emil CHIEF MEDICAL OFFICER | Calithera Biosciences, Inc. (CALA) | 23-Jan-23 | Payment of Exercise | 79 | $0.45 | $35.24 | (2%) 3.62K to 3.54K | |
| 25-Jan-23 4:00 PM View: | Molineaux Christopher SR. VP, DEVELOPMENT | Calithera Biosciences, Inc. (CALA) | 23-Jan-23 | Payment of Exercise | 217 | $0.45 | $96.80 | (< 1%) 38.08K to 37.87K | |
| 25-Jan-23 4:00 PM View: | Wong Stephanie See Remarks | Calithera Biosciences, Inc. (CALA) | 23-Jan-23 | Payment of Exercise | 317 | $0.45 | $141.41 | (5%) 6.96K to 6.65K | |
| 25-Jan-23 4:00 PM View: | Sjogren Eric SR. VP, DRUG DISCOVERY | Calithera Biosciences, Inc. (CALA) | 23-Jan-23 | Payment of Exercise | 279 | $0.45 | $124.46 | (3%) 8.75K to 8.47K | |
| 25-Jan-23 4:00 PM View: | Molineaux Susan PRESIDENT & CEO Director | Calithera Biosciences, Inc. (CALA) | 23-Jan-23 | Payment of Exercise | 526 | $0.45 | $234.65 | (1%) 38.39K to 37.87K | |
| 25-Jan-22 4:05 PM View: | Wong Stephanie See Remarks | Calithera Biosciences, Inc. (CALA) | 21-Jan-22 | Payment of Exercise | 5,586 | $0.49 | $2,745.52 | (4%) 144.89K to 139.3K | |
| 25-Jan-22 4:05 PM View: | Kuriakose Emil CHIEF MEDICAL OFFICER | Calithera Biosciences, Inc. (CALA) | 21-Jan-22 | Payment of Exercise | 666 | $0.49 | $327.34 | (< 1%) 68.03K to 67.37K | |
| 25-Jan-22 4:05 PM View: | Sjogren Eric SR. VP, DRUG DISCOVERY | Calithera Biosciences, Inc. (CALA) | 21-Jan-22 | Payment of Exercise | 4,794 | $0.49 | $2,356.25 | (3%) 177.23K to 172.43K | |
| 25-Jan-22 4:05 PM View: | Parlati Francesco SR. VP, RESEARCH | Calithera Biosciences, Inc. (CALA) | 21-Jan-22 | Payment of Exercise | 4,794 | $0.49 | $2,356.25 | (3%) 145.79K to 141.0K | |
| 06-Jan-22 9:00 PM View: | Kuriakose Emil CHIEF MEDICAL OFFICER | Calithera Biosciences, Inc. (CALA) | 04-Jan-22 | Payment of Exercise | 3,855 | $0.66 | $2,545.84 | (5%) 71.89K to 68.03K | 5% |
| 06-Jan-22 9:00 PM View: | Sjogren Eric SR. VP, DRUG DISCOVERY | Calithera Biosciences, Inc. (CALA) | 04-Jan-22 | Payment of Exercise | 18,077 | $0.66 | $11,938.10 | (9%) 195.31K to 177.23K | 5% |
| 06-Jan-22 9:00 PM View: | Parlati Francesco SR. VP, RESEARCH | Calithera Biosciences, Inc. (CALA) | 04-Jan-22 | Payment of Exercise | 18,077 | $0.66 | $11,938.10 | (11%) 163.87K to 145.79K | 5% |
| 06-Jan-22 9:00 PM View: | Wong Stephanie See Remarks | Calithera Biosciences, Inc. (CALA) | 04-Jan-22 | Payment of Exercise | 18,077 | $0.66 | $11,938.10 | (11%) 162.97K to 144.89K | 5% |
| 12-Nov-21 5:30 PM View: | Orford Keith Director | Calithera Biosciences, Inc. (CALA) | 11-Nov-21 | Market Sale | 48,190 | $0.88 | $42,407.20 | (42%) 114.28K to 66.09K | 1% |
| 10-Nov-21 7:28 PM View: | Molineaux Christopher SR. VP, DEVELOPMENT | Calithera Biosciences, Inc. (CALA) | 10-Nov-21 | Market Purchase | 100,000 | $0.85 | $84,670.00 | 15% 657.19K to 757.19K | (3%) |
| 12-Nov-21 5:30 PM View: | Orford Keith Director | Calithera Biosciences, Inc. (CALA) | 10-Nov-21 | Market Sale | 30,000 | $0.86 | $25,695.00 | (21%) 144.28K to 114.28K | (1%) |
| 10-Nov-21 7:31 PM View: | Drachman Jonathan G Director | Calithera Biosciences, Inc. (CALA) | 10-Nov-21 | Market Purchase | 200,000 | $0.86 | $171,900.00 | 100% 0 to 200.0K | (3%) |
| 10-Nov-21 7:34 PM View: | Molineaux Susan PRESIDENT & CEO Director | Calithera Biosciences, Inc. (CALA) | 10-Nov-21 | Market Purchase Duplicate | 100,000 | $0.85 | $84,670.00 | 15% 657.19K to 757.19K | (2%) |
| 09-Nov-21 7:39 PM View: | Orford Keith Director | Calithera Biosciences, Inc. (CALA) | 09-Nov-21 | Market Sale | 51,810 | $0.84 | $43,520.40 | (26%) 196.09K to 144.28K | |
| 09-Nov-21 7:32 PM View: | Kuriakose Emil CHIEF MEDICAL OFFICER | Calithera Biosciences, Inc. (CALA) | 08-Nov-21 | Payment of Exercise | 3,077 | $0.87 | $2,676.99 | (4%) 72.47K to 69.39K | |
| 09-Nov-21 7:35 PM View: | Sjogren Eric SR. VP, DRUG DISCOVERY | Calithera Biosciences, Inc. (CALA) | 08-Nov-21 | Payment of Exercise | 15,566 | $0.87 | $13,542.40 | (7%) 210.87K to 195.31K | |
| 09-Nov-21 7:28 PM View: | Parlati Francesco SR. VP, RESEARCH | Calithera Biosciences, Inc. (CALA) | 08-Nov-21 | Payment of Exercise | 15,566 | $0.87 | $13,542.40 | (9%) 179.44K to 163.87K | |
| 09-Nov-21 7:34 PM View: | Wong Stephanie See Remarks | Calithera Biosciences, Inc. (CALA) | 08-Nov-21 | Payment of Exercise | 15,566 | $0.87 | $13,542.40 | (9%) 178.53K to 162.97K | |
| 09-Nov-21 7:39 PM View: | Orford Keith Director | Calithera Biosciences, Inc. (CALA) | 05-Nov-21 | Grant | 30,000 | -- | -- | 18% 166.09K to 196.09K | |
| 09-Nov-21 7:35 PM View: | Sjogren Eric SR. VP, DRUG DISCOVERY | Calithera Biosciences, Inc. (CALA) | 05-Nov-21 | Grant | 30,000 | -- | -- | 17% 180.87K to 210.87K | |
| 09-Nov-21 7:28 PM View: | Parlati Francesco SR. VP, RESEARCH | Calithera Biosciences, Inc. (CALA) | 05-Nov-21 | Grant | 30,000 | -- | -- | 20% 149.44K to 179.44K | |
| 09-Nov-21 7:33 PM View: | Ray Sumita See Remarks | Calithera Biosciences, Inc. (CALA) | 05-Nov-21 | Grant | 12,000 | -- | -- | 13% 93.0K to 105.0K | |
| 09-Nov-21 7:37 PM View: | Molineaux Christopher SR. VP, DEVELOPMENT | Calithera Biosciences, Inc. (CALA) | 05-Nov-21 | Grant | 12,000 | -- | -- | 2% 645.19K to 657.19K | |
| 09-Nov-21 7:32 PM View: | Kuriakose Emil CHIEF MEDICAL OFFICER | Calithera Biosciences, Inc. (CALA) | 05-Nov-21 | Grant | 12,000 | -- | -- | 20% 60.47K to 72.47K | |
| 09-Nov-21 7:34 PM View: | Wong Stephanie See Remarks | Calithera Biosciences, Inc. (CALA) | 05-Nov-21 | Grant | 30,000 | -- | -- | 20% 148.53K to 178.53K | |
| 29-Oct-21 6:50 PM View: | Wong Stephanie See Remarks | Calithera Biosciences, Inc. (CALA) | 28-Oct-21 | Payment of Exercise | 45,965 | $1.89 | $86,873.90 | (24%) 194.5K to 148.53K | |
| 29-Oct-21 6:55 PM View: | Sjogren Eric SR. VP, DRUG DISCOVERY | Calithera Biosciences, Inc. (CALA) | 28-Oct-21 | Payment of Exercise | 45,965 | $1.89 | $86,873.90 | (20%) 226.84K to 180.87K | |
| 29-Oct-21 6:47 PM View: | Parlati Francesco SR. VP, RESEARCH | Calithera Biosciences, Inc. (CALA) | 28-Oct-21 | Payment of Exercise | 45,965 | $1.89 | $86,873.90 | (24%) 195.4K to 149.44K | |
| 29-Oct-21 6:55 PM View: | Sjogren Eric SR. VP, DRUG DISCOVERY | Calithera Biosciences, Inc. (CALA) | 27-Oct-21 | Grant | 90,000 | -- | -- | 66% 136.84K to 226.84K | |
| 29-Oct-21 6:47 PM View: | Parlati Francesco SR. VP, RESEARCH | Calithera Biosciences, Inc. (CALA) | 27-Oct-21 | Grant | 90,000 | -- | -- | 85% 105.4K to 195.4K | |
| 29-Oct-21 6:48 PM View: | Ray Sumita See Remarks | Calithera Biosciences, Inc. (CALA) | 27-Oct-21 | Grant | 36,000 | -- | -- | 63% 57.0K to 93.0K | |
| 29-Oct-21 6:51 PM View: | Molineaux Christopher SR. VP, DEVELOPMENT | Calithera Biosciences, Inc. (CALA) | 27-Oct-21 | Grant | 36,000 | -- | -- | 6% 609.19K to 645.19K | |
| 29-Oct-21 6:51 PM View: | Orford Keith Chief Medical Officer | Calithera Biosciences, Inc. (CALA) | 27-Oct-21 | Grant | 90,000 | -- | -- | 118% 76.09K to 166.09K | |
| 29-Oct-21 6:50 PM View: | Wong Stephanie See Remarks | Calithera Biosciences, Inc. (CALA) | 27-Oct-21 | Grant | 90,000 | -- | -- | 86% 104.5K to 194.5K | |
| 22-Jan-21 8:13 PM View: | Wong Stephanie See Remarks | Calithera Biosciences, Inc. (CALA) | 20-Jan-21 | Grant | 65,000 | -- | -- | 170% 38.16K to 103.16K | |
| 22-Jan-21 8:37 PM View: | Molineaux Susan PRESIDENT & CEO Director | Calithera Biosciences, Inc. (CALA) | 20-Jan-21 | Grant | 85,000 | -- | -- | 16% 519.19K to 604.19K | |
| 22-Jan-21 8:45 PM View: | Hecht Curtis CHIEF BUSINESS OFFICER | Calithera Biosciences, Inc. (CALA) | 20-Jan-21 | Grant | 65,000 | -- | -- | 238% 27.32K to 92.32K | |
| 22-Jan-21 8:14 PM View: | Sjogren Eric SR. VP, DRUG DISCOVERY | Calithera Biosciences, Inc. (CALA) | 20-Jan-21 | Grant | 60,000 | -- | -- | 81% 74.34K to 134.34K | |
| 22-Jan-21 8:27 PM View: | Parlati Francesco SR. VP, RESEARCH | Calithera Biosciences, Inc. (CALA) | 20-Jan-21 | Grant | 60,000 | -- | -- | 132% 45.4K to 105.4K | |
| 22-Jan-21 8:36 PM View: | Ray Sumita See Remarks | Calithera Biosciences, Inc. (CALA) | 20-Jan-21 | Grant | 42,000 | -- | -- | 280% 15.0K to 57.0K | |
| 22-Jan-21 8:44 PM View: | Molineaux Christopher SR. VP, DEVELOPMENT | Calithera Biosciences, Inc. (CALA) | 20-Jan-21 | Grant | 42,000 | -- | -- | 7% 562.19K to 604.19K | |
| 22-Jan-21 8:33 PM View: | Orford Keith Chief Medical Officer | Calithera Biosciences, Inc. (CALA) | 20-Jan-21 | Grant | 65,000 | -- | -- | 586% 11.09K to 76.09K | |
| 18-Dec-20 5:00 PM View: | Orford Keith Chief Medical Officer | Calithera Biosciences, Inc. (CALA) | 16-Dec-20 | Market Sale (Planned) | 2,447 | $6.00 | $14,682.00 | (18%) 13.54K to 11.09K | 12% |
| 26-May-20 5:52 PM View: | Bvf Partners L P/il 10% Owner | Calithera Biosciences, Inc. (CALA) | 21-May-20 | Market Sale | 2,283,600 | $6.00 | $13,701,600.00 | (25%) 9.24M to 6.96M | 12% |
